Skip to content

SRPT - Sarepta Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchS

Sarepta Therapeutics Inc

SRPT · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

S

SRPTSarepta Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $25.32
52-wk low: $14.68
Prev close: $21.73
Mkt cap: $1.90B
Fwd P/E: 6.6x
Beta: 0.20

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$779.3M

TS
Two Sigma
Q2 2026 13F
$82.6M
position
AQ
AQR
Q2 2026 13F

Earnings

Reported Aug 5, 2026

Earnings came in 23.5% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -6.9%
Forward P/E: 6.64
Market cap: $1.9B

Valuation

P/S0.96
P/B1.26

Quality

Operating margin13.0%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: SRPT
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $1.90B
Beta: 0.20

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

1.0x

P/B

1.3x

Profit margin

-6.9%

Op margin

+13.0%

ROE

-9.5%

$76.9M

position

MW

Marshall Wace

Q2 2026 13F

$39.6M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for SRPT

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

$0.42+23.5%

$0.34 expected

Next report

What the street expects next

ROE-9.5%

ROA-1.1%

Growth

Beta0.20